Optomed Plc Stock Exchange Release 8 February 2023 at 17:00, Helsinki
Proposal of Optomed’s Nomination Board
Optomed’s Nomination Board proposes the following to the next Annual General Meeting:
Number of Board members
The Nomination Board proposes, that the number of members of the Board of Directors for the term expiring at the end of the Annual General Meeting 2024 is six.
Additionally, the Nomination Board recommends to the Board of Directors of Optomed Plc that the Board of Directors proposes to the General Meeting that the minimum requirement for the minimum number of Board members is reduced from five to four in the articles of association of Optomed Plc.
Composition of the Board of Directors
The Nomination Board proposes to the Annual General Meeting that
Both new members are independent of the Company and its signicant shareholders.
Mars Duan has notified the Company that he is not available for re-election.
Proposal for the remuneration of the Board of Directors
The Nomination Board proposes to the Annual General Meeting that the annual remuneration payable to the members of the Board of Directors to be elected at the Annual General Meeting for the term until the end of the Annual General Meeting in 2024 remains unchanged as follows:
In addition, the Nomination Board proposes that a meeting fee in the amount of EUR 300 is paid to the committee chairmen and EUR 200 to committee members for each committee meeting. The Nomination Board proposes that 40 % of the Board remuneration is paid in Optomed shares and 60 % in cash. The remuneration will be paid once a year in August, after Optomed’s H1 report has been announced.
Nomination Board
Optomed’s Nomination Board consists of the following individuals:
Petri Salonen (chairman of Optomed’s Board of Directors) serves as the Nomination Board's expert member and Vesa Vanha-Honko acts as the chairman of the Nomination Board.
Optomed Plc
Further enquiries
Vesa Vanha-Honko, Chairman of the Nomination Board, vesa@vesasco.fi
Sakari Knuutti, secretary of the Nomination Board, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.
